NCT07150559

Brief Summary

The study is a multicenter, three-arm, open-label, randomized, parallel-controlled trial, which plans to enroll 306 participants diagnosed with acute type A aortic dissection (ATAAD) from 7 hospitals in China. All patients receive total arch replacement (TAR) combined with frozen elephant trunk (FET) implantation and are randomized to Group 1 (arch-clamping technique under mild hypothermia), Group 2 (arch-clamping technique under moderate hypothermia) and Group 3 (Sun's procedure using bilateral antegrade cerebral perfusion) in the ratio of 1:1:1. After a 1-year follow-up, the validity and safety of the mild hypothermic arch-clamping technique for ATAAD was evaluated via the incidence of major adverse events including death, renal replacement therapy, stroke, and paraplegia, as well as times of circulatory arrest, cardiopulmonary bypass, and mechanical ventilation, and length of ICU stay.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
306

participants targeted

Target at P75+ for not_applicable

Timeline
22mo left

Started Feb 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress13%
Feb 2026Feb 2028

First Submitted

Initial submission to the registry

August 25, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 2, 2025

Completed
5 months until next milestone

Study Start

First participant enrolled

February 1, 2026

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2028

Last Updated

December 15, 2025

Status Verified

September 1, 2025

Enrollment Period

1.9 years

First QC Date

August 25, 2025

Last Update Submit

December 7, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Major adverse events

    Major adverse events include death, renal replacement therapy, stroke, and paraplegia

    Thirty days and 12 months after the operation

Secondary Outcomes (4)

  • Circulatory arrest time

    During surgery

  • Cardiopulmonary bypass time

    During surgery

  • Mechanical ventilation time

    Discharge / 30 days after operation

  • The length of ICU stay

    Discharge / 30 days after operation

Study Arms (3)

Arch-clamping under mild hypothermia

EXPERIMENTAL

TAR + FET procedure is performed using arch-clamping technique under mild hypothermia.

Procedure: Arch-Clamping Technique under Mild Hypothermia

Arch-clamping under moderate hypothermia

EXPERIMENTAL

TAR + FET procedure is performed using arch-clamping technique under moderate hypothermia.

Procedure: Arch-Clamping Technique under Moderate Hypothermia

Sun's procedure using bACP

ACTIVE COMPARATOR

Total arch replacement and frozen elephant trunk implantation with moderate hypothermic circulatory arrest.

Procedure: Total Arch Replacement combined Frozen Elephant Trunk Implantation using Bilateral Antegrade Cerebral Perfusion under Moderate Hypothermic Circulatory Arrest

Interventions

This procedure is performed under moderate hypothermia. The branch arteries of the arch are reconstructed using the side arms of a Y-shaped graft, which allow bACP through the right axillary artery. A FET is deployed in the descending aorta and clamped together with the autologous aorta immediately, then distal perfusion is restored through the femoral artery. After the proximal procedures are completed, the distal anastomosis is performed in an end-to-end fashion. Finally, the main trunk of the Y-shaped graft is anastomosed to the proximal grafts.

Arch-clamping under moderate hypothermia

This procedure is performed under mild hypothermia. The branch arteries of the arch are reconstructed using the side arms of a Y-shaped graft, which allows bilateral antegrade cerebral perfusion (bACP) through the right axillary artery. A FET is deployed in the descending aorta and clamped together with the autologous aorta immediately, then distal perfusion is restored through the femoral artery. After the proximal procedures are completed, the distal anastomosis is performed in an end-to-end fashion. Finally, the main trunk of the Y-shaped graft is anastomosed to the proximal grafts.

Arch-clamping under mild hypothermia

This procedure is performed using bACP under MHCA, which involves FET deployment in the descending aorta followed by total arch replacement with a four-branched vascular graft. Deployment of the FET and suture of the distal anastomosis are completed during bACP. MHCA is terminated and distal reperfusion is initiated once the distal anastomosis is completed, and the left carotid artery is reconstructed first (after which bACP is stopped, rewarming is started and the brain is perfused bilaterally). The root or valve procedures and some concomitant operations, if indicated, are performed during the cooling phase.

Sun's procedure using bACP

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aortic CTA confirmed as ATAAD according to the 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease;
  • Adult patients (18-70 years) weighing 50-120 kg;
  • Time interval between the onset of symptoms and operation is less than 14 days;
  • Indications for total aortic arch replacement are available;
  • Signed informed consent and availability for follow-up.

You may not qualify if:

  • History of chronic renal failure, hepatocirrhosis, and hepatic insufficiency;
  • Severe gastrointestinal complications of non-aortic dissection, such as mesenteric ischemia, gastrointestinal bleeding, hepatopancreaticobiliary dysfunction, and intestinal obstruction;
  • History of severe cerebral infarction (with cerebral infarction sequels);
  • Preoperative intubation or unconsciousness;
  • Inflammatory aortic diseases, such as Takayasu arteritis and Behçet's disease, etc;
  • History of infectious aortic diseases;
  • History of cardiac and aortic surgery;
  • History of malignancy or previous radiotherapy;
  • Pregnant or feeding women, or anyone planning to reproduce during the test period;
  • Without an informed consent signature;
  • Participating in any other clinical trial;
  • Having other causes not eligible for operation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Anzhen Hospital

Beijing, Beijing Municipality, 100013, China

RECRUITING

MeSH Terms

Conditions

Hypothermia

Condition Hierarchy (Ancestors)

Body Temperature ChangesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Su-Wei Chen, Doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study is a multicenter, three-arm, open-label, randomized, parallel-controlled trial.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vice Chairman, Aortic Surgery Committee of Chinese Association of Cardiovascular Surgeons; President, Beijing Society for Thoracic and Cardiovascular Surgery; Director, Center for Aortic Surgery, Beijing Anzhen Hospital

Study Record Dates

First Submitted

August 25, 2025

First Posted

September 2, 2025

Study Start

February 1, 2026

Primary Completion (Estimated)

December 30, 2027

Study Completion (Estimated)

February 28, 2028

Last Updated

December 15, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations